VXRT
VAXART INC by Vaxart, Inc. (VXRT)
$36
About VAXART INC by Vaxart, Inc. (VXRT)
Vaxart, Inc. is a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology (VAAST) oral vaccine platform. It is developing prophylactic vaccine candidates that target a range of infectious diseases, including SARS-CoV-2, norovirus, seasonal influenza and respiratory syncytial virus (RSV). The company was founded by Sean Tucker in March 2004 and is headquartered in South San Francisco, CA.
Details
Daily high
$0.38
Daily low
$0.36
Price at open
$0.36
52 Week High
$0.84
52 Week Low
$0.33
Market cap
89.6M
Dividend yield
-
Volume
253,336
Avg. volume
309,646
P/E ratio
3.02
VAXART INC by Vaxart, Inc. News
Details
Daily high
$0.38
Daily low
$0.36
Price at open
$0.36
52 Week High
$0.84
52 Week Low
$0.33
Market cap
89.6M
Dividend yield
-
Volume
253,336
Avg. volume
309,646
P/E ratio
3.02